You are here
- Home
- Therapy Areas
- Gastrointestinal
An Epidemiological, Postmarketing Observational Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease (GERD) on Patients' Daily Life
- Disease
- gastroesophageal reflux disease
- Drug Name
- non drug study (gastrointestinal)
- Sponsor
- AstraZeneca
- Drug Status
- Non-Drug
- Phase
- Non-Interventional Study
- Start Date
- Oct 4, 2010
- Study Name
- NIS-GRS-DUM-2010/1
- Study Id
- NIS-GRS-DUM-2010/1
- ClinicalTrials.gov ID
- NCT01134367
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
- May 5, 2011
